| 摘要 |
<p>The present invention is directed to cyclic substituted fused pyrrolocarbazoles and isoindolones having formula (I). The invention also is directed to methods for making and using the cyclic substituted fused pyrrolocarbazoles and isoindolones. The compounds are useful as agents for the regulation of protein kinase.</p> |
